AI Financial Fiction - Story #225

Abbott Laboratories announces the development of a groundbreaking device that can detect early signs of fatal diseases in a person's blood. But with the device costing millions, only the wealthy can afford to have their health monitored, leaving the rest of the population susceptible to unknowingly developing fatal illnesses. Healthcare inequality has reached new heights with Abbott Labs at the forefront - creating a world where only the rich can access life-saving technology.

Story #225 out of 480 ChatGPT stories